Nanoengineered bioink improves tumor model accuracy

Scientists from the Terasaki Institute for Biomedical Innovation have developed a nanoengineered bioink with improved bonding and cross-linking capabilities for 3D bioprinting of tumor models.

NHS sets sights on ending cervical cancer by 2040 with HPV vaccine drive – Pharmaceutical Technology

Share this article Currently, the NHS offers MSD’s Gardasil 9 to both boys and girls aged 12 to 13 years and to those from higher-risk

November 15, 2023

New York Blood Center Enterprises buys Talaris’ cell therapy facilities in CDMO expansion

The New York Blood Center Enterprises (NYBCe) is absorbing two of Talaris Therapeutics’ autologous and allogeneic cell and gene therapy facilities to expand its CDMO

October 5, 2023

Patient dies in Beam Therapeutics trial of CRISPR sickle cell treatment

A patient with sickle cell disease died while participating in a clinical trial of a CRISPR-based treatment from Beam Therapeutics, threatening to overshadow early signals

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.